DRL gets DCGI's nod to conduct COVID-19 vaccine phase 2/3 human trials

Trial to be a multi-centre and randomised controlled study, says Dr Reddy's

DRL gets DCGI's nod to conduct COVID-19 vaccine phase 2/3 human trials

A small bottle labelled with a ‘Vaccine COVID-19’ sticker and a medical syringe in this illustration taken April 10, 2020. Reuters

Hyderabad, October 17

Dr Reddy’s Laboratories Ltd. and Russian Direct Investment Fund, Russia’s sovereign wealth fund, on Saturday announced that they have received approval from the Drug Control General of India to conduct an adaptive Phases 2/3 human clinical trial for Sputnik V vaccine in India.

The city-based drug maker said in a press release that this will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study.

Earlier in September 2020, Dr.Reddys and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.

Dr Reddy’s Co-chairman and Managing Director GV Prasad said: “This is a significant development that allows us to commence the clinical trial in India and we are committed to bringing in a safe and efficacious vaccine to combat the pandemic”.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said: “We are pleased to collaborate with the Indian regulators and in addition to Indian clinical trial data, we will provide safety and immunogenicity study from the Russian phase 3 clinical trial. This data will further strengthen the clinical development of Sputnik V vaccine in India”.

On August 11, 2020, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against COVID-19 based on the human adenoviral vectors platform.

Sputnik V is currently undergoing Phase 3 clinical trials in Russia and the proposed number of subjects is 40,000.

Additionally, Phase 3 clinical trial of the vaccine commenced in the UAE last week. PTI

 

Don't Miss

Arrival of pets has been the exact disruption we needed

Arrival of pets has been the exact disruption we needed

Modi to Ganguly, how different is BCCI?

Modi to Ganguly, how different is BCCI?

Sins of the father & the aftermath

Sins of the father & the aftermath

Summer of 69, in Himalayas

Summer of 69, in Himalayas

Congress in need of overhaul

Congress in need of overhaul

Top Stories

Night curfew to be imposed in Punjab as Capt announces fresh curbs from December 1

Night curfew to be imposed in Punjab as Capt announces fresh curbs from December 1

Fine for not wearing masks to be doubled from Rs 500 to Rs 1...

'Delhi Chalo' protest: Hundreds of farmers gather along Punjab-Haryana border

'Delhi Chalo' protest: Hundreds of farmers gather along Punjab-Haryana border

Haryana imposes Section 144 to prevent assembly of protester...

Cops rang doorbell at 1.30 am, forcibly took my husband away: Haryana Zila Parishad member’s wife

Cops rang doorbell at 1.30 am, forcibly took my husband away: Haryana Zila Parishad member’s wife

Haryana police personnel raided the houses of dozens of farm...

A host of issues on menu as Amarinder and Sidhu meet over lunch

A host of issues on menu as Amarinder and Sidhu meet over lunch

The meeting could soon see the reinduction of Sidhu into the...

Supreme Court refuses to transfer Guru Granth Sahib sacrilege case out of Punjab

Supreme Court refuses to transfer Guru Granth Sahib sacrilege case out of Punjab

Eight Dera Sacha Sauda members were charged with sacrilege f...

Cities

View All